Filing Flows › Materials › Cabot (CBT)
Cabot (CBT) earnings and revenue breakdown
Latest: Q4 FY26 · 8-K filed Nov 2, 2026
Q4 FY26 Revenue up 12% year over year to $1.0B · 7¢ of every $1 of revenue kept as net profit · operating margin 12.0%
Cabot made $1.0B in Q4 FY26 (+12% Y/Y). Operating margin 12.0%, net earnings $66.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 8-K filed Nov 2, 2026 (preliminary, from the earnings release).
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.0B in Q4 FY26, up 12% year over year and up 3% from the previous quarter.
Gross margin was 20.2%, down 4.3 points from Q4 FY25. Operating profit was $0.12B, a 12.0% margin (down 3.2 points year over year). Operating profit fell $0.02B even though revenue rose $0.11B versus Q4 FY25, so costs grew faster than sales. Operating expenses grew 0% against revenue growth of 12%. Net earnings were $0.07B, up 53% year over year. The effective tax rate was 34.2%.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q4 FY26 | 8-K | Nov 2, 2026 | $1.0B | +12% | 12.0% | $66.0M | — |
| Q3 FY26 | 10-Q | Aug 4, 2026 | $982M | +6% | 10.0% | $6.0M | $75.0M |
| Q2 FY26 | 10-Q | May 6, 2026 | $904M | -3% | 14.3% | $68.0M | $77.0M |
| Q1 FY26 | 10-Q | Feb 4, 2026 | $849M | -11% | 15.2% | $73.0M | $126M |
| Q4 FY25 | 10-K | Nov 24, 2025 | $899M | -10% | 15.2% | $43.0M | $219M |
| Q3 FY25 | 10-Q | Aug 5, 2025 | $923M | -9% | 18.1% | $101M | $249M |
| Q2 FY25 | 10-Q | May 7, 2025 | $936M | -8% | 17.3% | $94.0M | $73.0M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Cabot
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials
In its own words, from its 8-K, filed Aug 3, 2026.
Cabot against its Miscellaneous Chemical Products peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +12% against the peers' median +9%. Operating margin: 12.0% against the peers' median 8.2%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CBT Cabot | Q4 FY26 | $1.0B | +12% | 12.0% |
| ESI Element Solutions | Q3 2026 | $995M | +52% | 11.4% |
| OEC Orion S.A. | Q3 2026 | $473M | +5% | 4.8% |
| WDFC WD 40 | Q4 FY26 | $177M | +8% | 10.8% |
| FTK Flotek Industries | Q3 2026 | $114M | +104% | 15.7% |
| ARQ Arq | Q3 2026 | $38.2M | +9% | 8.2% |
| FSI Flexible Solutions International | Q2 2026 | $7.6M | -33% | -29.2% |
| ASPI ASP Isotopes | Q2 2026 | $5.1M | +328% | -667.5% |
| PURE Pure Bioscience | Q4 FY26 | $659K | -14% | -76.3% |
Source: Cabot 8-K on SEC EDGAR · CIK 16040 · Miscellaneous Chemical Products
13F: who owns CBT and who is buying
More on CBT
- How Cabot makes money: revenue by segment
- Cabot next earnings date and what analysts expect
- Cabot stock forecast, price target and fair value
- Who owns Cabot stock: holders, funds and Congress trades
- Cabot guidance and outlook
- Is Cabot a takeover target? LBO and rumors
- Cabot recalls, complaints and regulation
History
Every quarter: Q4 FY26 results · Q3 FY26 results · Q2 FY26 results · Q1 FY26 results · Q4 FY25 results · Q3 FY25 results · Q2 FY25 results